Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra N Nowak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|December 31, 2002
Aspirin dose for prevention of cardiovascular disease in diabeticsSandra N Nowak, Linda A Jaber
Journal of Clinical Pharmacology|January 26, 2002
Insulin-metformin combination therapy in obese patients with type 2 diabetesLinda A Jaber, Sandra N Nowak, Richard R Slaughter
Diabetes Care|July 30, 2002
Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinicSandra N Nowak, Renu Singh, Anthony Clarke, et al.
Journal of Clinical Pharmacology|December 5, 2002
Pioglitazone: effect on CYP3A4 activitySandra N Nowak, David J Edwards, Anthony Clarke, et al.
The Annals of Pharmacotherapy|April 2, 2009
Mitigation of medication mishaps via medication therapy managementVanita K Pindolia, Lesia Stebelsky, Tanya M Romain, et al.
Diabetes Care|January 28, 2003
Epidemiology of diabetes among Arab AmericansLinda A Jaber, Morton B Brown, Adnan Hammad, et al.
The Annals of Pharmacotherapy|January 31, 2002
Correlation between activated clotting time and activated partial thromboplastin timesMaureen A Smythe, John M Koerber, Sandra N Nowak, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|December 31, 2002
Aspirin dose for prevention of cardiovascular disease in diabeticsSandra N Nowak, Linda A Jaber
Journal of Clinical Pharmacology|January 26, 2002
Insulin-metformin combination therapy in obese patients with type 2 diabetesLinda A Jaber, Sandra N Nowak, Richard R Slaughter
Diabetes Care|July 30, 2002
Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinicSandra N Nowak, Renu Singh, Anthony Clarke, et al.
Journal of Clinical Pharmacology|December 5, 2002
Pioglitazone: effect on CYP3A4 activitySandra N Nowak, David J Edwards, Anthony Clarke, et al.
The Annals of Pharmacotherapy|April 2, 2009
Mitigation of medication mishaps via medication therapy managementVanita K Pindolia, Lesia Stebelsky, Tanya M Romain, et al.
Diabetes Care|January 28, 2003
Epidemiology of diabetes among Arab AmericansLinda A Jaber, Morton B Brown, Adnan Hammad, et al.
The Annals of Pharmacotherapy|January 31, 2002
Correlation between activated clotting time and activated partial thromboplastin timesMaureen A Smythe, John M Koerber, Sandra N Nowak, et al.
Pageof 1